Annual CFF
$1.08 M
-$355.54 M-99.70%
December 31, 2021
Summary
- As of February 10, 2025, CCXI annual cash flow from financing activities is $1.08 million, with the most recent change of -$355.54 million (-99.70%) on December 31, 2021.
- During the last 3 years, CCXI annual CFF has fallen by -$23.62 million (-95.62%).
Performance
CCXI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
$1.86 M
-$1.24 M-39.94%
June 30, 2022
Summary
- As of February 10, 2025, CCXI quarterly cash flow from financing activities is $1.86 million, with the most recent change of -$1.24 million (-39.94%) on June 30, 2022.
- Over the past year, CCXI quarterly CFF has increased by +$1.12 million (+151.35%).
Performance
CCXI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
$8.16 M
+$1.12 M+15.96%
June 30, 2022
Summary
- As of February 10, 2025, CCXI TTM cash flow from financing activities is $8.16 million, with the most recent change of +$1.12 million (+15.96%) on June 30, 2022.
- Over the past year, CCXI TTM CFF has increased by +$4.45 million (+119.68%).
Performance
CCXI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
CCXI Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -99.7% | +151.3% | +119.7% |
| 3 y3 years | -95.6% | -38.5% | -91.4% |
| 5 y5 years | -85.6% | +32.5% | -91.4% |
CCXI Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -49.3% | at low | at high | -86.7% |
| 5 y | 5-year | -99.7% | at low | -99.4% | -252.8% | -97.8% | -86.7% |
| alltime | all time | -99.7% | -251.3% | -99.4% | -252.8% | -97.8% | -88.0% |
ChemoCentryx Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $1.86 M(-39.9%) | $8.16 M(+16.0%) |
| Mar 2022 | - | $3.10 M(-15.6%) | $7.04 M(+549.9%) |
| Dec 2021 | $1.08 M(-99.7%) | $3.68 M(-852.6%) | $1.08 M(-13.3%) |
| Sep 2021 | - | -$489.00 K(-165.9%) | $1.25 M(-66.4%) |
| Jun 2021 | - | $742.00 K(-126.0%) | $3.71 M(-98.9%) |
| Mar 2021 | - | -$2.85 M(-174.1%) | $338.10 M(-5.2%) |
| Dec 2020 | $356.62 M(+276.1%) | $3.85 M(+94.5%) | $356.62 M(-3.5%) |
| Sep 2020 | - | $1.98 M(-99.4%) | $369.66 M(+0.5%) |
| Jun 2020 | - | $335.12 M(+2037.9%) | $367.91 M(+927.1%) |
| Mar 2020 | - | $15.68 M(-7.1%) | $35.82 M(-62.2%) |
| Dec 2019 | $94.82 M(+283.9%) | $16.88 M(+7145.1%) | $94.82 M(+13.1%) |
| Sep 2019 | - | $233.00 K(-92.3%) | $83.85 M(-1.4%) |
| Jun 2019 | - | $3.03 M(-95.9%) | $85.02 M(-13.9%) |
| Mar 2019 | - | $74.67 M(+1164.2%) | $98.72 M(+299.7%) |
| Dec 2018 | $24.70 M(+228.6%) | $5.91 M(+318.9%) | $24.70 M(+3.2%) |
| Sep 2018 | - | $1.41 M(-91.6%) | $23.93 M(+2.1%) |
| Jun 2018 | - | $16.73 M(+2453.9%) | $23.43 M(+189.0%) |
| Mar 2018 | - | $655.00 K(-87.2%) | $8.11 M(+7.9%) |
| Dec 2017 | $7.52 M(-14.8%) | $5.13 M(+464.9%) | $7.52 M(+109.9%) |
| Sep 2017 | - | $909.00 K(-35.4%) | $3.58 M(+27.7%) |
| Jun 2017 | - | $1.41 M(+2100.0%) | $2.80 M(-67.7%) |
| Mar 2017 | - | $64.00 K(-94.7%) | $8.67 M(-1.7%) |
| Dec 2016 | $8.82 M | $1.20 M(+801.5%) | $8.82 M(+8.0%) |
| Sep 2016 | - | $133.00 K(-98.2%) | $8.17 M(+0.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $7.28 M(+3365.7%) | $8.13 M(+292.7%) |
| Mar 2016 | - | $210.00 K(-61.7%) | $2.07 M(-5.5%) |
| Dec 2015 | $2.19 M(+22.2%) | $548.00 K(+489.2%) | $2.19 M(+5.8%) |
| Sep 2015 | - | $93.00 K(-92.4%) | $2.07 M(+7.9%) |
| Jun 2015 | - | $1.22 M(+268.3%) | $1.92 M(+95.9%) |
| Mar 2015 | - | $331.00 K(-22.7%) | $980.00 K(-45.3%) |
| Dec 2014 | $1.79 M(-97.3%) | $428.00 K(-837.9%) | $1.79 M(+36.6%) |
| Sep 2014 | - | -$58.00 K(-120.8%) | $1.31 M(-13.3%) |
| Jun 2014 | - | $279.00 K(-75.6%) | $1.51 M(-97.7%) |
| Mar 2014 | - | $1.14 M(-2300.0%) | $66.46 M(-0.5%) |
| Dec 2013 | $66.78 M(+16.3%) | -$52.00 K(-136.4%) | $66.78 M(-0.8%) |
| Sep 2013 | - | $143.00 K(-99.8%) | $67.35 M(+0.2%) |
| Jun 2013 | - | $65.23 M(+4355.5%) | $67.19 M(+3504.5%) |
| Mar 2013 | - | $1.46 M(+187.1%) | $1.86 M(-96.8%) |
| Dec 2012 | $57.44 M(+400.1%) | $510.00 K(-3287.5%) | $57.44 M(+0.9%) |
| Sep 2012 | - | -$16.00 K(-83.0%) | $56.93 M(-14.8%) |
| Jun 2012 | - | -$94.00 K(-100.2%) | $66.83 M(-0.1%) |
| Mar 2012 | - | $57.04 M(>+9900.0%) | $66.87 M(+482.3%) |
| Dec 2011 | $11.48 M(+1115.2%) | $0.00(-100.0%) | $11.48 M(0.0%) |
| Sep 2011 | - | $9.89 M(<-9900.0%) | $11.48 M(+621.4%) |
| Jun 2011 | - | -$54.00 K(-103.3%) | $1.59 M(-3.3%) |
| Mar 2011 | - | $1.65 M | $1.65 M |
| Dec 2010 | $945.00 K(-157.7%) | - | - |
| Dec 2009 | -$1.64 M(-103.4%) | - | - |
| Dec 2008 | $47.89 M | - | - |
FAQ
- What is ChemoCentryx annual cash flow from financing activities?
- What is the all time high annual CFF for ChemoCentryx?
- What is ChemoCentryx annual CFF year-on-year change?
- What is ChemoCentryx quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for ChemoCentryx?
- What is ChemoCentryx quarterly CFF year-on-year change?
- What is ChemoCentryx TTM cash flow from financing activities?
- What is the all time high TTM CFF for ChemoCentryx?
- What is ChemoCentryx TTM CFF year-on-year change?
What is ChemoCentryx annual cash flow from financing activities?
The current annual CFF of CCXI is $1.08 M
What is the all time high annual CFF for ChemoCentryx?
ChemoCentryx all-time high annual cash flow from financing activities is $356.62 M
What is ChemoCentryx annual CFF year-on-year change?
Over the past year, CCXI annual cash flow from financing activities has changed by -$355.54 M (-99.70%)
What is ChemoCentryx quarterly cash flow from financing activities?
The current quarterly CFF of CCXI is $1.86 M
What is the all time high quarterly CFF for ChemoCentryx?
ChemoCentryx all-time high quarterly cash flow from financing activities is $335.12 M
What is ChemoCentryx quarterly CFF year-on-year change?
Over the past year, CCXI quarterly cash flow from financing activities has changed by +$1.12 M (+151.35%)
What is ChemoCentryx TTM cash flow from financing activities?
The current TTM CFF of CCXI is $8.16 M
What is the all time high TTM CFF for ChemoCentryx?
ChemoCentryx all-time high TTM cash flow from financing activities is $369.66 M
What is ChemoCentryx TTM CFF year-on-year change?
Over the past year, CCXI TTM cash flow from financing activities has changed by +$4.45 M (+119.68%)